Advertisement

Interleukin-17 as a predictor of sepsis in polytrauma patients: a prospective cohort study

  • M. Ahmed Ali
  • E. S. Mikhael
  • A. Abdelkader
  • L. Mansour
  • R. El Essawy
  • R. El Sayed
  • A. Eladawy
  • A. Mukhtar
Original Article

Abstract

Sepsis is one of the most serious complications after major trauma, and may be associated with increased mortality. We sought to determine whether there is an association between serum levels of interleukin-17 (IL-17) at the time of admission to the intensive care unit (ICU) and the development of sepsis. We evaluated 100 adult patients with major trauma admitted to the surgical ICU over a 6-month period. Serum levels of IL-17, IL-6, and TNF-α were determined by enzyme-linked immunosorbent assays (ELISA). The IL-17 rs1974226 genotype was determined by real-time PCR. In both non-adjusted and adjusted analyses, IL-17 was the only biomarker significantly associated with sepsis [median serum IL-17 of 72 pg/mL in sepsis versus 37 pg/mL in those without sepsis, P = 0.0001; adjusted odds ratio (OR) 3.2, P = 0.02]. No significant association was found among IL-17 rs1974226 genotypes and related serum cytokine levels. These data suggest that elevated serum IL-17 may increase the susceptibility for septic complications in polytrauma patients and so could be a useful biomarker for trauma patient management.

Keywords

IL-17 Trauma Sepsis Polymorphism IL-6 TNF 

Notes

Compliance with ethical standards

Conflict of interest

Mai Ahmed Ali Elsayed, Emily Samir Mikhael, Amr Abdelkader, Lamia Mansour, Riham El Essawy, Riham El Sayed, Akram Eladawy, and Ahmed Mukhtar declare that they have no conflict of interest.

Ethical standards

This research includes human participants.

Informed consent

Approval of the research ethics committee of Cairo University and an informed consent were obtained from the patients’ next of kin.

References

  1. 1.
    Wang Z, Jiang J. An overview of research advances in road traffic trauma in China. Traffic Inj Prev. 2003;4(1):9–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Ciesla DJ, Moore EE, Johnson JL, Burch JM, Cothren CC, Sauaia A. A 12-year prospective study of postinjury multiple organ failure: has anything changed? Arch Surg. 2005;140(5):432–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Moore FA, Moore EE. Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin N Am. 1995;75(2):257–77.CrossRefPubMedGoogle Scholar
  4. 4.
    Keel M, Trentz O. Pathophysiology of polytrauma. Injury. 2005;36(6):691–709.CrossRefPubMedGoogle Scholar
  5. 5.
    Ward NS, Casserly B, Ayala A. The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. Clin Chest Med. 2008;29(4):617–25.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional specialization of interleukin-17 family members. Immunity. 2011;34(2):149–62.CrossRefPubMedGoogle Scholar
  7. 7.
    Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 2008;36(3):941–52.CrossRefPubMedGoogle Scholar
  8. 8.
    Dominguez-Villar M, Hafler D a. Immunology. An innate role for IL-17. Science. 2011;332(6025):47–8.CrossRefPubMedGoogle Scholar
  9. 9.
    Schwarzenberger P, Huang W, Ye P, Oliver P, Manuel M, Zhang Z, Bagby G, Nelson S, Kolls JK. Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol. 2000;164(9):4783–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644–55.CrossRefPubMedGoogle Scholar
  11. 11.
    Frangen TM, Bogdanski D, Schinkel C, Roetman B, Muhr G, Koller M. Systemic IL-17 after severe injuries. Shock. 2008;29(4):462–427.CrossRefPubMedGoogle Scholar
  12. 12.
    Roy AK, Mc Gorrian C, Treacy C, Kavanaugh E, Brennan A, Mahon NG. A comparison of traditional and Novel definitions (RIFLE, AKIN, and KDIGO) of acute kidney injury for the prediction of outcomes in acute decompensated heart failure. Cardiorenal Med. 2013;3(1):26–37.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Acute respiratory distress syndrome: the Berlin Definition. JAMA, 307:2526–33, 2012.Google Scholar
  14. 14.
    Nieves E, Tobo LF, Beltra JA. Bacterial translocation in abdominal trauma and postoperative infections. J Trauma. 2011;71(63):1258–61.CrossRefPubMedGoogle Scholar
  15. 15.
    Sebastian, Tranca. Cristina Petrișor, Natalia Hagau, Constantin Ciuce. Can APACHE II, SOFA, ISS, and RTS severity scores be used to predict septic complications in multiple trauma patients? JCCM. 2016;2(3):124–30.Google Scholar
  16. 16.
    Chunfang Gu Ling, Wua Xiaoxia, Li. IL-17 family: cytokines, receptors and signaling. Cytokine. 2013;64(2):1–9.Google Scholar
  17. 17.
    Nakada TA, Russell JA, Boyd JH, Walley KR. IL17A genetic variation is associated with altered susceptibility to Gram-positive infection and mortality of severe sepsis. Crit Care. 15(5), 2011.Google Scholar
  18. 18.
    Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10(7):479–89.CrossRefPubMedGoogle Scholar
  19. 19.
    Hashmi S, Zeng QT. Role of interleukin-17 and interleukin-17-induced cytokines interleukin-6 and interleukin-8 in unstable coronary artery disease. Coron Artery Dis. 2006;17(8):699–706.CrossRefPubMedGoogle Scholar
  20. 20.
    Jin H, Liu Z, Xiao Y, Fan X, Yan J, Liang H. Prediction of sepsis in trauma patients. Burns Trauma. 2014;2(3):106–13.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg. 2009;33:558–66CrossRefPubMedGoogle Scholar
  22. 22.
    Keel M, Harter L, Reding T, Sun LK, Hersberger M, Seifert B, et al. Pancreatic stone protein is highly increased during posttraumatic sepsis and activates neutrophil granulocytes. Crit Care Med. 2009;37:1642–8.CrossRefPubMedGoogle Scholar
  23. 23.
    Egger G, Aigner R, Glasner A, Hofer HP, Mitterhammer H, Zelzer S. Blood polymorphonuclear leukocyte migration as a predictive marker for infections in severe trauma: Comparison with various inflammation parameters. Intensive Care Med. 2004;30:331–4.CrossRefPubMedGoogle Scholar
  24. 24.
    Flores JM, Jimenez PI, Rincon MD, Marquez JA, Navarro H, Arteta D, et al. Early risk factors for sepsis in patients with severe blunt trauma. Injury. 2001;32:5–12.CrossRefPubMedGoogle Scholar
  25. 25.
    Paunel-Gorgulu A, Flohe S, Scholz M, Windolf J, Logters T. Increased serum soluble Fas after major trauma is associated with delayed neutrophil apoptosis and development of sepsis. Crit Care. 2011;15:R20.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Giannoudis PV, Smith MR, Evans RT, Bellamy MC, Guillou PJ. Serum CRP and IL-6 levels after trauma. Not predictive of septic complications in 31 patients. Acta Orthop Scand. 1998;69:184–8.CrossRefPubMedGoogle Scholar
  27. 27.
    Giannoudis PV, Smith RM, Banks RE, Windsor AC, Dickson RA, Guillou PJ. Stimulation of inflammatory markers after blunt trauma. Br J Surg.1998;85:986–90CrossRefPubMedGoogle Scholar
  28. 28.
    Giamarellos-Bourboulis EJ, Mouktaroudi M, Tsaganos T, Koutoukas P, Spyridaki E, Pelekanou A, et al. Evidence for the participation of soluble triggering receptor expressed on myeloid cells-1 in the systemic inflammatory response syndrome after multiple trauma. J Trauma. 2008;65:1385–90.CrossRefPubMedGoogle Scholar
  29. 29.
    van Beelen AJ, Zelinkova Z, Taanman-Kueter EW, Muller FJ, Hommes DW, Zaat SA, Kapsenberg ML, de Jong EC. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity. 2007;27:660–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Niebuhr M, Gathmann M, Scharonow H, Mamerow D, Mommert S, Balaji H, Werfel T. Staphylococcal alpha-toxin is a strong inducer of interleukin-17 in humans. Infect Immun. 2011;79:1615–22.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, Laslo C, Hagau R, Petrescu M, Studnicska DM. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care. 2010;14:R203.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Cho JS, Pietras EM, Garcia NC, Ramos RI, Farzam DM, Monroe HR, Magorien JE, Blauvelt A, Kolls JK, Cheung AL, Cheng G, Modlin RL, Miller LS. IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest. 2010;120:1762–73.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Kagami S, Rizzo HL, Kurtz SE, Miller LS, Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol. 2010;185:5453–62.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y. Differential roles of interleukin-17A and – 17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity. 2009;30:108–19.CrossRefPubMedGoogle Scholar
  35. 35.
    Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190:624–31.CrossRefPubMedGoogle Scholar
  36. 36.
    Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, Akitsu A, Fujikado N, Kusaka T, Kubo S, Chung SH, Komatsu R, Miura N, Adachi Y, Ohno N, Shibuya K, Yamamoto N, Kawakami K, Yamasaki S, Saito T, Akira S, Iwakura Y. Dectin-2 recognition of alpha-mannans and induction of Th17cell differentiation is essential for host defense against Candida albicans. Immunity. 2010;32:681–91.CrossRefPubMedGoogle Scholar
  37. 37.
    Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med. 2009;206:299–311.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Schelonka RL, Maheshwari A, Carlo WA, Taylor S, Hansen NI, Schendel DE, Thorsen P, Skogstrand K, Hougaard DM, Higgins RD. T cell cytokines and the risk of blood stream infection in extremely low birth weight infants. Cytokine. 2011;53:249–55.CrossRefPubMedGoogle Scholar
  39. 39.
    Accardo Palumbo A, Forte GI, Pileri D, Vaccarino L, Conte F, D‘Amelio L, Palmeri M, Triolo A, D‘Arpa N, Scola L, Misiano G, Milano S, Lio D. Analysis of IL-6, IL-10 and IL-17 genetic polymorphisms as risk factors for sepsis development in burned patients. Burns. 2011;38(2):208–13.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  1. 1.Department of Anesthesia, Faculty of MedicineCairo UniversityCairoEgypt
  2. 2.Department of Clinical and Chemical Pathology, Faculty of MedicineCairo UniversityCairoEgypt

Personalised recommendations